COMMUNIQUÉS West-GlobeNewswire

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

08/10/2024 - 22:05

PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]

T2 Biosystems to Host Business Update Call on October 10, 2024

08/10/2024 - 22:05

LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a [...]

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

08/10/2024 - 22:05

SAN JOSE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]

Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer

08/10/2024 - 22:05

SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a series of ongoing research collaborations to study the use [...]

ENCER Now Available on Amazon: A Game-Changer in Relief from Fatigue Related to Cancer Treatment

08/10/2024 - 22:29

Dr. Yakov Freed, developer of ENCER Photo credit: ENCER DOVER, Del., Oct. 08, 2024 (GLOBE NEWSWIRE) -- ENCER , the groundbreaking homeopathic remedy designed to provide relief from fatigue associated with cancer [...]

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

07/10/2024 - 14:30

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, is pleased [...]

Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors

07/10/2024 - 14:30

BOSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect [...]

Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical

07/10/2024 - 14:33

SAN MATEO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today filed a [...]

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

07/10/2024 - 14:45

Approval allows for larger field treatment of actinic keratosis (AK) on face and scalp with Ameluz ® -PDT using the BF-RhodoLED or the RhodoLED XL lamp Supplemental New Drug Application (sNDA) supported by two Phase 1 [...]

Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines

07/10/2024 - 14:45

Galecto will focus on cancer and liver disease, leveraging existing clinical stage asset GB1211 Bolsters pipeline by obtaining global rights to BRM-1420, a novel dual ENL-YEATS and FLT3 inhibitor for multiple genetic [...]

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

07/10/2024 - 14:55

– KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes complex transcription factor regulatory networks [...]

T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results

07/10/2024 - 15:00

Achieved 35% increase in total revenue compared to prior year period LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens [...]

VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland

07/10/2024 - 15:00

— QSIVA now available in all Scandinavian countries — AMSTERDAM, Oct. 07, 2024 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, today announced the availability of QSIVA ® (phentermine and topiramate modified- [...]

Revolution Medicines to Deliver Multiple Presentations at the 2024 AACR-NCI-EORTC Symposium and Host Investor Webcast

07/10/2024 - 15:00

Pancreatic ductal adenocarcinoma (PDAC) data from RMC-6236 (RAS(ON) multi-selective inhibitor) and RMC-9805 (RAS (ON) G12D-selective inhibitor) monotherapy studies to be featured in two late-breaking presentations [...]

Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)

07/10/2024 - 15:00

BMF-219 is an investigational oral covalent menin inhibitor developed to regenerate insulin-producing beta cells Two trial-in-progress oral presentations to feature Phase II study design of oral covalent menin inhibitor [...]

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

07/10/2024 - 15:05

LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that [...]

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

07/10/2024 - 15:05

MIAMI, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Sanara MedTech Inc. Announces Changes to Its Board of Directors

07/10/2024 - 15:15

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving [...]

New York Medical Device Development Legacy Company MIDI Expands to Toronto

07/10/2024 - 15:35

MIDI is expanding to Toronto to join Canada’s largest MedTech ecosystem, celebrating over 50 years of medical device development excellence TORONTO , Oct. 07, 2024 (GLOBE NEWSWIRE) -- MIDI , a leader in medical device [...]